Phytic acid-based nanomedicine shows promise for metabolic dysfunction-associated steatohepatitis therapy
by Higher Education PressCePA exerts a liver-targeted mTOR repressive function, alleviating MASH progression and fat accumulation in high-fat diet-fed mice. Credit: Fenghua Xu, Shoujie Zhao, Yejing Zh
Updated on: July 17,2024
0

Phytic acid-based nanomedicine shows promise for metabolic dysfunction-associated steatohepatitis therapy
by Higher Education PressCePA exerts a liver-targeted mTOR repressive function, alleviating MASH progression and fat accumulation in high-fat diet-fed mice. Credit: Fenghua Xu, Shoujie Zhao, Yejing Zh
Updated on:July 17,2024
0
